All patients completed the Oxford Knee Questionnaire preoperatively as well as at 1 and 2 years postoperatively. Their stated kneeling ability and total scores were analysed with a perfect score for kneeling ability being 4, and 48 the maximum total score.
There was a more striking difference with respect to kneeling ability with the fixed bearing variants performing better, (Rotaglide 1.4; 0.9 and Uniglide 1.9; 1.4), However, the greatest difference was between the UKR and TKR groups (UKR 1.7; TKR 1.2). Pre-operatively less than 2% of TKR patients (7% of the UKR patients) could kneel. Post-operatively, the patients’ kneeling ability improved with 21% for the mobile bearing, 32% of fixed bearing UKR patients. The TKR patients kneeling ability was 13% of the mobile, 26% of fixed bearing patients were able to kneel with little or no difficulty. In all groups the stated kneeling ability was poor with less than 50% of any group being able to kneel with ease or only minor difficulty.
Only two trochlea components were loose at the time of revision and one patella had a large amount of macroscopic wear. All other components were found to be well fixed with minimal wear at the time of revision. There were no difficulties in removing either component. No cases required augments or stemmed femoral components due to bone loss. Patients undergoing revision surgery did report improvement in their post revision outcome scores compared with their pre-operative scores. The average Oxford Knee Score improved from 17 to 23, Bristol Knee Pain Scores improved from 11 to 20 and Bristol Knee Functional Scores improved from 15 to 16. These results are poorer than those recorded by the overall cohort of primary PFA.
Data was also prospectively collected on 215 UKR patients who received the same Unicompartmental implant (AMC, Uniglide, Corin, UK). One hundred and thirty six patients (Mean age: 62 yrs) had a mobile insert and 79 (mean age: 65 yrs) a fixed insert. All patients completed the Oxford Knee Questionnaire preoperatively as well as at 1 and 2 years postoperatively. Their stated kneeling ability and total scores were analysed with a perfect score for kneeling ability being 4 and 48 the maximum total score.
There was a more striking difference with respect to kneeling ability with the fixed- bearing variants performing better, (Rotaglide 1.4; 0.9 and Uniglide 1.9; 1.4), However, the greatest difference was between the UKR and TKR groups (UKR 1.7; TKR 1.2). Pre-operatively less than 2% of TKR patients (7% of the UKR patients) could kneel. Post-operatively, the patients’ kneeling ability improved with 21% for the mobile bearing, 32% of fixed bearing UKR patients. The TKR patients kneeling ability was 13% of the mobile, 26% of fixed bearing patients were able to kneel with little or no difficulty. In all groups the stated kneeling ability was poor with less than 50% of any group being able to kneel with ease or only minor difficulty.
The median pain score rose from 15/40 pre-operatively to 40 points at eight years. The median (MPS) rose from 10/30 points pre-operatively to 25 points at eight years. The median (OKS) rose from 18/48 pre-operatively to 38 at eight years. 87% of knees had mild or no pain at eight years. There were no cases of failure of the prosthesis itself. All 15 revisions resulted from progression of arthrititis in the tibio-femoral joint. The five-year survival rate for all causes with 86 cases at risk was 96%.
99 knees were followed for 15 years and 21 knees for 20 years. The average Bristol knee score of the surviving knees fell from 86 to 79 during the second decade. A previous study showed an 89% 10 year survivor-ship and this is now extended to 82% at 15 years and 76.5% at 20 years.
The purpose of this study was to determine the incidence of revision total knee replacement (TKR) within 5 years of the index procedure at a large multi-surgeon unit using a single prosthesis and to determine the cause of failure of those implants. This was a retrospective review of all primary Kine-max Plus TKR performed at the Avon Orthopaedic Center between 1.1.1990 and 1.1.2000. Cases were identified that required revision arthroplasty in any form within 5 years of the index procedure. Case notes and Xrays were reviewed to determine causes of failure. There were 2826 primary Kinemax Plus TKR performed during the study period. Of these 20 were known to have required revision surgery within 5 years. 8 were revised for deep infection of the prosthesis and 12 for aseptic causes. The overall incidence of premature failure of the Kinemax Plus TKR at 5 years was 0.71%. The incidence of aseptic premature failure at 5 years was 0.42%. Detailed examination of the clinical records indicated that some form of technical error at the time of the index arthroplasty was responsible for the early failure of 6 prostheses. This equates to 0.21% of the procedures performed. Aseptic loosening of the remaining 6 cases could not be attributed to a specific cause.
We identified 148 patients who had undergone a revision total knee replacement using a single implant system between 1990 and 2000. Of these 18 patients had died, six had developed a peri-prosthetic fracture and ten had incomplete records or radiographs. This left 114 with prospectively-collected radiographs and Bristol knee scores available for study. The height of the joint line before and after revision total knee replacement was measured and classified as either restored to within 5 mm of the pre-operative height or elevated if it was positioned more than 5 mm above the pre-operative height. The joint line was elevated in 41 knees (36%) and restored in 73 (64%). Revision surgery significantly improved the mean Bristol knee score from 41.1 ( Our findings show that restoration of the joint line at revision total knee replacement gives a significantly better result than leaving it unrestored by more than 5 mm. We recommend the greater use of distal femoral augments to help to achieve this goal.
We report the mid-term results of a new patellofemoral arthroplasty for established isolated patellofemoral arthritis. We have reviewed the experience of 109 consecutive patellofemoral resurfacing arthroplasties in 85 patients who were followed up for at least five years. The five-year survival rate, with revision as the endpoint, was 95.8% (95% confidence interval 91.8% to 99.8%). There were no cases of loosening of the prosthesis. At five years the median Bristol pain score improved from 15 of 40 points (interquartile range 5 to 20) pre-operatively, to 35 (interquartile range 20 to 40), the median Melbourne score from 10 of 30 points (interquartile range 6 to 15) to 25 (interquartile range 20 to 29), and the median Oxford score from 18 of 48 points (interquartile range 13 to 24) to 39 (interquartile range 24 to 45). Successful results, judged on a Bristol pain score of at least 20 at five years, occurred in 80% (66) of knees. The main complication was radiological progression of arthritis, which occurred in 25 patients (28%) and emphasises the importance of the careful selection of patients. These results give increased confidence in the use of patellofemoral arthroplasty.
There have been several reports of good survivorship and excellent function at ten years with fixed-bearing unicompartmental knee replacement. However, little is known about survival beyond ten years. From the Bristol database of over 4000 knee replacements, we identified 203 St Georg Sled unicompartmental knee replacements (174 patients) which had already survived ten years. The mean age of the patients at surgery was 67.1 years (35.7 to 85) with 67 (38.5%) being under 65 years at the time of surgery. They were reviewed at a mean of 14.8 years (10 to 29.4) from surgery to determine survivorship and function. There were 99 knees followed up for 15 years, 21 for 20 years and four for 25 years. The remainder failed, were withdrawn, or the patient had died. In 58 patients (69 knees) the implant was The mean Bristol knee score of the surviving knees fell from 86 (34 to 100) to 79 (42 to 100) during the second decade. Survivorship to 20 years was 85.9% (95% CI 82.9% to 88.9%) and at 25 years was 80% (95% CI 70.2% to 89.8%). Satisfactory survival of a fixed-bearing unicompartmental knee replacement can be achieved into the second decade and beyond.
Lowered by more than 5 mm Restored Elevated more than 5 mm
Joint line elevation >
8mm has been associated with inferior clinical outcome, and depression associated with retropatellar pain and increased risk of patella subluxation. Recently, modifications have been made to the Kine-max-Plus Total Knee System instrumentation, theoretically providing better internal fixation to prevent a varus cut and a 12 mm measured resection from the “normal” tibial plateau. This study aims to examine whether these changes result in an improvement in alignment, and a more reliable restoration of joint line.
Following total hip arthroplasty (THA) and total knee arthroplasty (TKR) only the ‘visible’ measured blood loss is usually known. This underestimates the ‘true’ total loss, as some loss is ‘hidden’. Correct management of blood loss should take hidden loss into account. We studied 101 THAs and 101 TKAs (with re-infusion of drained blood). Following THA, the mean total loss was 1510 ml and the hidden loss 471 ml (26%). Following TKA, the mean total loss was 1498 ml. The hidden loss was 765 ml (49%). Obesity made no difference with either operation. THA involves a small hidden loss, the total loss being 1.3 times that measured. However, following TKA, there may be substantial hidden blood loss due to bleeding into the tissues and residual blood in the joint. The true total loss can be determined by doubling the measured loss.
The aim of this study was to examine causes of the failed knee arthroplasty. Since 1980 the Bristol Knee Replacement Registry has prospectively recorded data on 3024 patients. Complete original and 5 year follow up data was available on 999 knees. The surgery was judged a failure if there was no improvement in the American Knee Society score at 5 years or if there had been a revision within that time. The prosthesis used was Kinematic in 471 knees, the Medial Unicompartmental Sled in 258 knees, the Kinemax Plus in 134 knees and a variety of other designs. At 5 years, 79 (7. 9%) either showed no improvement in the American Knee Society score or had been revised. The failure rate was 7% for the Kinematic, 7% for the medial Sled and 5% for the Kinemax Plus. 20% of the less frequently used designs failed. Five (0. 5%) knee replacements failed because of infection. 22 knees (2. 2%) had significant comorbidity that precluded a satisfactory functional outcome. For 7 knees (0. 7%), the patient exhibited patterns of abnormal illness behaviour that were thought to explain the poor outcome. A further 27 knees (2. 7%) failed because of technical errors either at the time of surgery (13 cases, 1. 3%), or in selecting a prosthesis which failed prematurely (14 cases 1. 4%). No cause for failure could be identified in 12 cases (1. 2%). The high failure rate amongst infrequently used prosthesis emphasises the need to use established designs. No cause for failure could be identified in 12 cases and 5 were due to infection; such cases are hard to avoid. This study shows the importance of assessing both the overall physical and psychological state of the patient if disappointing results are to be avoided. The most frequent cause of an unsatisfactory outcome was a technical one, which should be avoidable.
Isolated patellofemoral arthritis occurs in up to 10% of patients suffering osteoarthritis of the knee. Previous reports of several different patellofemoral designs have given indifferent results. The Lubinus prosthesis has been shown to have a 50% failure rate at eight years in a study of 76 cases. The main reasons for failure were mal-alignment, wear, impingement and disease progression. As a result of these studies, a new prosthesis was designed to solve some of these problems. The Avon patellofemoral arthroplasty was first implanted in September 1996. The cases have been entered into a prospective review with evaluations at eight months, two years and five years. The outcome was assessed using pain scores, Bartlett’s patella score and the Oxford knee score. To date, 186 knees have been treated; over 100 knees have been reviewed at two years and 20 knees at five years. The main pain score improved from a pre-operative level of 13.5 points out of 40 to 33.5 points at two years and 36 at five years. The mean pre-operative movement was 109° and this increased to 120° at five years. The Bartlett patella score improved from a pre-operative level of 10.5 points out of 30 pre-operatively to 23 points at two years and 25 at five years. The Oxford knee score was 20 points out of 48 pre-operatively and this improved to 35 points at two years and 40 points at five years. One patient developed subluxation, which required distal soft tissue realignment. No other patient has developed problems with alignment or wear. Ten knees have developed evidence of disease progression usually in the medial compartment of which six have required revision to a total knee replacement. The results to date suggest that this improved design has all but eliminated the previous problems of malalignment and early wear. The functional results are as good or better than those of a total knee replacement. There is a low complication rate and an excellent range of movement. Disease progression remains a potential problem. This type of prosthesis offers a reasonable alternative to total knee replacement in this small group of patients with isolated, early patellofemoral disease.
The aim of this study was to report our experience of patellofemoral arthroplasty in isolated osteoarthrosis. Material and Methods: The Lubinus Patellofemoral Arthroplasty was performed between 1989 and 1995 in 76 knees. The Avon Patella Femoral Arthroplasty was used from 1996 to 2001 in 187 knees. The average age of the patients was 65.5 years (range 36–87) with a male to female ratio of 1: 5. All the patients have been prospectively reviewed with standard radiographs, the Bristol Knee Score, and more recently Bartlett and Oxford scores.
The Avon Arthroplasty with improved design features for better tracking and congruity was introduced in 1996 and 187 have now been inserted in 147 patients. One hundred and nine knees have been followed for 8 months and 82 have completed the 2 year follow-up. Two patients have undergone revision to a TKR 97.5% (survivorship 2 out of 82). Three patients have had a unicompartmental arthroplasty added for disease progression. There have been no cases of patella maltracking or subliaxation. Four year survivorship for moderate pain and revision is 96% (79 out of 82). Functional scores compared favourably with parallel series of total knee replacements. Conclusion: The medium-term results of the Lubinus Patello Femoral Arthroplasty are unsatisfactory. We suggest the use of this prosthesis should be discontinued. The Avon Arthroplasty has improved results in the short-term.